»ó´Ü¿©¹é
±â»ç (Àüü 19°Ç)
[Cover Story] ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á Æз¯´ÙÀÓÀº Çõ½Å Áß ÀÌ»óµ· ±âÀÚ 2022-11-16 12:14
[Sub Story] Çѱ¹Àο¡¼­ ½ºÅ¸Æ¾ÀÇ LDL-C °­ÇÏÈ¿°ú ÀÌ»óµ· ±âÀÚ 2022-11-16 12:10
[Sub Story] ´ëÇѹα¹Àº ¿Ö 55mg/dL ¹Ì¸¸ ¿Ü¸éÇÒ ¼ö ¾ø¾ú³ª? ÀÌ»óµ· ±âÀÚ 2022-11-16 12:10
[Sub Story] ¼­±¸´Â ¹» ±Ù°Å·Î 55mg/dL ¹Ì¸¸Á¶Àý ±Ç°íÇß³ª? ÀÌ»óµ· ±âÀÚ 2022-11-16 12:09
[Sub Story] 55mg/dL ¹Ì¸¸ ¸ñǥġ ¾à¹°Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâÀº? ÀÌ»óµ· ±âÀÚ 2022-11-16 12:03
¶óÀÎ
[Sub Story] ½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ¿¡ ½ºÅ¸Æ¾ ±Ç°í ÀÌ»óµ· ±âÀÚ 2022-11-16 11:56
[Sub Story] ¿¡Á¦Æ¼¹Ìºê¡¤PCSK9¾ïÁ¦Á¦ ±Ç°íµî±Þ »óÇâ ÀÌ»óµ· ±âÀÚ 2022-11-16 11:52
[Sub Story] °íÁß¼ºÁö¹æÇ÷Áõ µ¿¹Ý½Ã ½ºÅ¸Æ¾¸¸À¸·Î ½ÉÇ÷°üÁúȯ ¸ø¸·¾Æ ÀÌ»óµ· ±âÀÚ 2022-11-16 11:50
[Interview] ¡°Æä³ëÇǺ극ÀÌÆ® Àå±âÅõ¿© ±Ù°Å ¸¶·ÃÇß´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:47
[Sub Story] ÁöÁú¡¤Ç÷¾Ð Á¾ÇÕÄ¡·á Æз¯´ÙÀÓ ¿­¸°´Ù ÀÌ»óµ· ±âÀÚ 2022-11-16 11:42
¶óÀÎ
[Drug Review] ·Î¼ö¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê/Åڹ̻縣ź¿¡ ¾Ï·ÎµðÇɱîÁö ´õÇß´Ù ÀÌ»óµ· ±âÀÚ 2022-11-16 11:38
[Primary Expert Opinion] [1Â÷ ÀÇ·á±â°ü ½ÃÁ¡ÀÇ ½ÇÁúÀûÀÎ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®Àü·«]

ȯÀÚº° LDL-C ¸ñÇ¥¼³Á¤ Çʿ䡦º¹¿ë¼øÀÀµµ °³¼±¿¡µµ ½Å°æ½á¾ß

THE MOST 2022-11-16 11:33
[Interview] ¡°°Ç°­°ËÁøÀ² °¡Àå ³·Àº Á¦ÁÖµµ¹Î Æò»ý ÁÖÄ¡ÀÇ »ç¸í ´ÙÇÒ °Í¡± THE MOST 2022-11-16 11:29
[Conference Report] ¡°TZD, 1Â÷Àü·«À¸·Î °í·ÁÇؾߡ± ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:26
[Conference Report] ´ç´¢º´, ½ÄÈÄÇ÷´ç¡¤º¯µ¿¼º ÁßÁ¡°ü¸®¿¡

Àü´Ü°èºÎÅÍ Àû±Ø¡¤¾ÈÀü LDL-C Á¶Àý ÇÊ¿ä

ÀÌ»óµ· ±âÀÚ 2022-11-16 11:11
¶óÀÎ
[Conference Report] 3Á¦º´¿ë¿ä¹ý, Àå±â°£ È¿°ú ¹× ¾ÈÀü¼º º¸¿© ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:03
[Conference Report] ´ç´¢º´ ȯÀÚÀÇ CVD À§ÇèÀÎÀÚ Á¶ÀýÈ¿°ú ÀçÈ®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2022-11-16 10:58
[Conference Report] SGLT-2i + DPP-4i Àü·«, Ç÷´çÁ¶Àý¡¤ÀáÀçÀû ½É±Ù ÇýÅà ±â´ë ÀÓ¼¼Çü ±âÀÚ 2022-11-16 10:54
[Deep in Guideline] [2022 ACC ºñ½ºÅ¸Æ¾¿ä¹ý Àü¹®°¡ ÄÁ¼¾¼­½º]

ºñ½ºÅ¸Æ¾ LDL-C °­ÇÏÀü·« ¾÷µ¥ÀÌÆ®

ÀÓ¼¼Çü ±âÀÚ 2022-11-16 10:52
Back to Top